Jim Cramer says he likes these 5 Nasdaq stocks for 2023

Jim Cramer says he likes these 5 Nasdaq stocks for 2023


Cramer explains why many of the stocks listed in the Nasdaq Composite don't fit his investing rubric

CNBC’s Jim Cramer on Thursday gave investors a list of stocks that he believes could be worthwhile additions to investors’ portfolios.

All of his picks are listed in the Nasdaq Composite. While the index is heavy with tech stocks that were hammered last year, there are still names that could perform well even in a recessionary environment, according to Cramer.

“In an index that’s been folded, spindled and mutilated, I am still feeling good about a few of these stocks,” he said.

Here are his picks:

T-Mobile

  • Cramer said that he expects the company to continue taking market share from competitors.

Regeneron Pharmaceuticals

  • “Regeneron’s got a broad pipeline with a ridiculously cheap stock. I think it’s a really, really excellent situation, especially if you’re expecting a severe recession,” he said.

PepsiCo

  • The beverage giant rivals Procter & Gamble when it comes to the best consumer packaged goods company in the U.S., he said, though he acknowledged that the stock’s valuation is a bit higher than he would like.

American Electric Power

  • Cramer said that he likes the stock because the company is well-run, and utility stocks tend to perform well during economic slowdowns.

Dollar Tree

  • While he does like the stock compared to other retailers listed on the Nasdaq, Cramer said that he still prefers TJX Companies.

Disclaimer: Cramer’s Charitable Trust owns shares of TJX Companies.

Jim Cramer says he likes these 5 Nasdaq stocks

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

Inside the booming business of wellness third spaces and membership clubs
Business

Inside the booming business of wellness third spaces and membership clubs

A few years ago, Grace Guo began to crave places in New York City where hanging out with friends didn’t have to involve alcohol. Newly sober and surrounded by friends who also chose not to drink, Guo said she wanted alternatives to the typical social scene. After some research, she landed on Bathhouse and Othership: […]

Read More
FDA vaccine head will step down in April after string of controversial decisions
Business

FDA vaccine head will step down in April after string of controversial decisions

The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human Services Headquarters in Washington, DC on April 22, 2025. Nathan Posner | Anadolu | Getty Images A key U.S. Food and Drug Administration official who oversees vaccines and biotech treatments will step down from the […]

Read More
FDA reversals leave investors worrying about the fates of other experimental drugs
Business

FDA reversals leave investors worrying about the fates of other experimental drugs

Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from the U.S. Food and Drug Administration.  The FDA in the past year has denied or discouraged the applications of at least eight drugs, according to RTW Investments, including a gene therapy for Huntington’s disease from […]

Read More